<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ACC</journal-id>
<journal-id journal-id-type="hwp">spacc</journal-id>
<journal-title>European Heart Journal: Acute Cardiovascular Care</journal-title>
<issn pub-type="ppub">2048-8726</issn>
<issn pub-type="epub">2048-8734</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/2048872612455143</article-id>
<article-id pub-id-type="publisher-id">10.1177_2048872612455143</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Acute coronary syndromes</subject>
<subj-group subj-group-type="heading">
<subject>Original scientific papers</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Reperfusion delay in patients treated with primary percutaneous coronary intervention: insight from a real world Danish ST-segment elevation myocardial infarction population in the era of telemedicine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Schoos</surname><given-names>Mikkel M</given-names></name>
<xref ref-type="aff" rid="aff1-2048872612455143">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sejersten</surname><given-names>Maria</given-names></name>
<xref ref-type="aff" rid="aff1-2048872612455143">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hvelplund</surname><given-names>Anders</given-names></name>
<xref ref-type="aff" rid="aff2-2048872612455143">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Madsen</surname><given-names>Mette</given-names></name>
<xref ref-type="aff" rid="aff2-2048872612455143">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lønborg</surname><given-names>Jacob</given-names></name>
<xref ref-type="aff" rid="aff1-2048872612455143">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Steinmetz</surname><given-names>Jacob</given-names></name>
<xref ref-type="aff" rid="aff3-2048872612455143">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Treschow</surname><given-names>Philip M</given-names></name>
<xref ref-type="aff" rid="aff4-2048872612455143">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pedersen</surname><given-names>Frants</given-names></name>
<xref ref-type="aff" rid="aff1-2048872612455143">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jørgensen</surname><given-names>Erik</given-names></name>
<xref ref-type="aff" rid="aff1-2048872612455143">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Grande</surname><given-names>Peer</given-names></name>
<xref ref-type="aff" rid="aff1-2048872612455143">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kelbæk</surname><given-names>Henning</given-names></name>
<xref ref-type="aff" rid="aff1-2048872612455143">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Clemmensen</surname><given-names>Peter</given-names></name>
<xref ref-type="aff" rid="aff1-2048872612455143">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-2048872612455143"><label>1</label>Department of Cardiology, Copenhagen University Hospital, Denmark</aff>
<aff id="aff2-2048872612455143"><label>2</label>Department of Public Health, University of Copenhagen, Denmark</aff>
<aff id="aff3-2048872612455143"><label>3</label>Department of Anesthesia, Copenhagen University Hospital, Denmark</aff>
<aff id="aff4-2048872612455143"><label>4</label>Department of Anesthesia, District General Hospital Nykøbing Falster, Denmark</aff>
<author-notes>
<corresp id="corresp1-2048872612455143">Mikkel M Schoos, Blegdamsvej 9, 2100 Copenhagen, Denmark. Email: <email>mikkel.schoos@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>1</volume>
<issue>3</issue>
<fpage>200</fpage>
<lpage>209</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>5</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>6</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The European Society of Cardiology 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">European Society of Cardiology</copyright-holder>
</permissions>
<abstract>
<sec id="section1-2048872612455143">
<title>Background:</title>
<p>Reperfusion delay in ST-segment elevation myocardial infarction (STEMI) predicts adverse outcome. We evaluated time from alarm call (system delay) and time from first medical contact (PCI-related delay), where fibrinolysis could be initiated, to balloon inflation in a pre-hospital organization with tele-transmitted electrocardiograms, field triage and direct transfer to a 24/7 primary percutaneous coronary intervention (PPCI) center.</p>
</sec>
<sec id="section2-2048872612455143">
<title>Methods and results:</title>
<p>This was a single center cohort study with long-term follow-up in 472 patients. The PPCI center registry was linked by person identification number to emergency medical services (EMS) and National Board of Health databases in the period of 2005–2008. Patients were stratified according to transfer distances to PPCI into zone 1 (0–25 km), zone 2 (65–100 km) and zone 3 (101–185 km) and according to referral by pre-hospital triage. System delay was 86 minutes (interquartile range (IQR) 72–113) in zone 1, 133 (116–180) in zone 2 and 173 (145–215) in zone 3 (<italic>p</italic>&lt;0.001). PCI-related delay in directly referred patients was 109 (92–121) minutes in zone 2, but exceeded recommendations in zone 3 (139 (121–160)) and for patients admitted via the local hospital (219 (171–250)). System delay was an independent predictor of mortality (<italic>p</italic>&lt;0.001).</p>
</sec>
<sec id="section3-2048872612455143">
<title>Conclusions:</title>
<p>Pre-hospital triage is feasible in 73% of patients. PCI-related delay exceeded European Society of Cardiology (ESC) guidelines for patients living &gt;100 km away and for non-directly referred patients. Sorting the PPCI centers catchment area into geographical zones identifies patients with long reperfusion delays. Possible solutions are pharmaco-invasive regiments, research in early ischemia detection, airborne transfer and EMS personnel education that ensures pre-hospital triage.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Acute myocardial infarction</kwd>
<kwd>STEMI</kwd>
<kwd>primary PCI</kwd>
<kwd>pre-hospital triage</kwd>
<kwd>reperfusion delay</kwd>
<kwd>telemedicine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section4-2048872612455143" sec-type="intro">
<title>Introduction</title>
<p>In patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PPCI), reperfusion delay predicts the extent of salvaged myocardium,<sup><xref ref-type="bibr" rid="bibr1-2048872612455143">1</xref></sup> final myocardial infarct size,<sup><xref ref-type="bibr" rid="bibr2-2048872612455143">2</xref></sup> chronic heart failure (CHF)<sup><xref ref-type="bibr" rid="bibr3-2048872612455143">3</xref></sup> and long term mortality.<sup><xref ref-type="bibr" rid="bibr4-2048872612455143">4</xref></sup> Guidelines emphasize the need to minimize all time delays, especially within the first two hours of symptom onset.<sup><xref ref-type="bibr" rid="bibr5-2048872612455143">5</xref></sup> The implementation of telemedicine by pre-hospital 12-lead ECG recording and transmission to an attending cardiologist in a percutaneous coronary intervention (PCI)-capable center reduces system delay more than one hour by-passing local hospitals.<sup><xref ref-type="bibr" rid="bibr6-2048872612455143">6</xref></sup> However, marked system delay may still be the reality for patients redirected for PPCI by telemedicine. STEMI patients are at high risk of developing arrhythmic complications within the first hours of symptom onset,<sup><xref ref-type="bibr" rid="bibr7-2048872612455143">7</xref></sup> making safe ambulance transport pivotal. Proper identification of patients with expected long reperfusion delay seems important in order to foresee the need for early reperfusion alternatives to PPCI. This requires assessment of PCI-related delay, defined by European Society of Cardiology (ESC) guidelines<sup><xref ref-type="bibr" rid="bibr5-2048872612455143">5</xref></sup> as the time interval from first medical contact (FMC) where, at least in principle, reperfusion therapy could be given, to balloon inflation. Transfer distances in Denmark were estimated to be sufficiently short to replace fibrinolytic therapy by PPCI as a national reperfusion strategy after Danish Acute Myocardial Infarction-2 (DANAMI II), demonstrating that PPCI is superior to fibrinolytic therapy in patients treated within two hours of FMC.<sup><xref ref-type="bibr" rid="bibr8-2048872612455143">8</xref></sup></p>
<p>Experiences from established STEMI network systems that ensure ECG telemetry and bypass community hospitals and emergency rooms in PCI-capable hospitals, all show the feasibility of providing PPCI to the majority of the population and that systems of care improve clinical outcomes and their results have influenced guidelines. Nevertheless, not all patients referred for PPCI may receive optimal mechanical reperfusion (FMC to balloon &lt;120 min).<sup><xref ref-type="bibr" rid="bibr9-2048872612455143">9</xref><xref ref-type="bibr" rid="bibr10-2048872612455143"/><xref ref-type="bibr" rid="bibr11-2048872612455143"/><xref ref-type="bibr" rid="bibr12-2048872612455143"/><xref ref-type="bibr" rid="bibr13-2048872612455143"/><xref ref-type="bibr" rid="bibr14-2048872612455143"/><xref ref-type="bibr" rid="bibr15-2048872612455143"/>–<xref ref-type="bibr" rid="bibr16-2048872612455143">16</xref></sup></p>
<p>Our main purpose was therefore to evaluate reperfusion delay by the objective time intervals of emergency medical services (EMS) alarm call to first balloon inflation (system delay) and PCI-related delay in the era of telemedicine for STEMI patients and to assess the influence of system delay on the safety of ground transfer and mortality.</p>
</sec>
<sec id="section5-2048872612455143" sec-type="methods">
<title>Methods</title>
<sec id="section6-2048872612455143">
<title>Pre-hospital triage</title>
<p>Pre-hospital triage by telemedicine was started in the Copenhagen Region in 2002 and in Southern Zealand in 2005 and fully implemented in both regions at the beginning of the study period in May 2005. All included patients could therefore in theory be directly transferred from the injury scene to a PPCI center, by-passing local hospitals. Physician-manned Mobile Emergency Care Units (MECU) assisted on scene or were available for rendezvous, i.e. meeting the ambulance en-route to the PPCI center when transfer distances were substantial. This allowed advanced medical life support when necessary. The LIFEPAK 12 (Physio-Control, Inc., Redmond, Washington) defibrillator/monitor was used for transmitting the digital 12-lead ECG through the global system for mobile communication (GSM) network to a receiving station located in the cardiac care unit. The on-call cardiologist interpreted the ECG and called the ambulance/MECU to conduct a short health personnel interview. In case of a likely STEMI diagnosis based on ECG and interview, the ambulance/MECU was re-routed directly to the pre-alerted catheterization laboratory. ECG STEMI criteria were ≥2-mm ST-segment elevation in men and ≥1.5 mm in women in leads V2–V3 and ≥1 mm in ≥2 leads on all other leads.</p>
</sec>
<sec id="section7-2048872612455143">
<title>Geographical area</title>
<p>Rigshospitalet’s catchment area in the study period consisted of Copenhagen County (540,000 inhabitants, 90 km<sup>2</sup>), Storstroem County (262,781 inhabitants and 3398 km<sup>2</sup>) and Western Zealand County (307,207 inhabitants, 2983 km<sup>2</sup>). We chose Storstroem County as our study area because it geographically encompasses the farthest transfer distances (periphery 65–185 km) and compared it to Copenhagen County (zone 1) (0–25 km) as our control area. Study patients were divided in zones according to injury site. Storstroem County was arbitrarily divided at 100 km into zone 2 (Zealand South) (65–100 km) and zone 3 (Lolland Falster Islands) (101–185 km). Zone 1 has fast ground ambulance transfer, granted by the vicinity of a PPCI capable center and pre-hospital triage. Zones 2 and 3 comprised longer transfer distances and patients in whom a pre-hospital diagnosis was established by telemedicine but without necessarily direct referral for PPCI.</p>
</sec>
<sec id="section8-2048872612455143">
<title>Study population</title>
<p>This was a single center cohort study of STEMI patients with follow-up. The inclusion period was 1 May 2005 to 31 January 2008. Ambulance/MECU charts held time information on alarm call, arrival at scene, departure from scene and hospital arrival, gathered in pre-hospital databases. We searched these databases from Storstroem County and Copenhagen County with the selection criteria of a tentative pre-hospital STEMI diagnosis. Identified patients were then compared to entries in our in-hospital procedural PPCI database, which holds baseline and PCI procedural characteristics, timepoints and outcome, information on patient recalled symptom onset and discharge diagnosis. Patients that figured in both a pre- and in-hospital database with an identical personal identification number, relevant diagnosis, identical transfer and treatment date, and relevant system time information represent the study population (<xref ref-type="fig" rid="fig1-2048872612455143">Figure 1</xref>). False positive patients were excluded. Information on all-cause mortality and whether or not a patient initially was admitted to a local emergency room, were retrieved from databases provided by the Danish National Board of Health. Valid Cases were above 80% of the total patient population for all baseline variables except for family history of ischemic heart disease (IHD: 76.1%), dyslipidemia (63.1%), former myocardial infarction (MI: 60.4%) and body mass index (BMI: 39.6%). Regarding outcome variables, valid cases were above 80% of the total patient population except for patient delay (64.2%), PCI related delay (76.1%) and treatment delay (62.5%). The study was approved by the Danish Data Protection Agency (2011-41-5849) and The National Board of Health (7-505-29-1710/1/FSE).</p>
<fig id="fig1-2048872612455143" position="float">
<label>Figure 1.</label>
<caption><p>Map of Zealand, Denmark with geographical zones. Green: zone 1 (Greater Copenhagen Region (0–25 km)); Yellow: zone 2 (Southern Zealand (65–100 km)); Red: zone 3 (Island of Lolland-Falster (100–185 km)).</p>
<p>STEMI: ST-segment elevation myocardial infarction; NSTEMI/UAP: non ST-segment elevation myocardial infarction/unstable angina pectoris.</p></caption>
<graphic xlink:href="10.1177_2048872612455143-fig1.tif"/></fig>
</sec>
<sec id="section9-2048872612455143">
<title>Definitions of system time points</title>
<p>System time points were defined according to recent studies<sup><xref ref-type="bibr" rid="bibr3-2048872612455143">3</xref>,<xref ref-type="bibr" rid="bibr4-2048872612455143">4</xref>,<xref ref-type="bibr" rid="bibr17-2048872612455143">17</xref>,<xref ref-type="bibr" rid="bibr18-2048872612455143">18</xref></sup> and ESC guidelines.<sup><xref ref-type="bibr" rid="bibr5-2048872612455143">5</xref></sup> Patient delay was defined as patient-recalled symptom onset to EMS alarm call (‘alarm call’ in the EMS chart refers to ambulance dispatchment time, when the EMS personnel enters the ambulance, which implies a few minutes delay after the proper alarm call); pre-hospital system delay as time from EMS alarm call to arrival at a primary PCI center; door to balloon as time from arrival at PCI center to balloon inflation; system delay as time from EMS alarm call to balloon inflation; PCI-related delay as time from FMC to balloon inflation; treatment delay as time from symptom onset to balloon inflation.</p>
</sec>
<sec id="section10-2048872612455143">
<title>Statistics</title>
<p>Statistical analysis compared zones 1, 2 and 3. Primary outcome measures were system and PCI-related delay. Secondary outcome measures were all cause long term mortality in association with system delay and complications during transfer. Continuous variables are presented as median with interquartile range (IQR). Discrete data are presented as frequencies and percentages. The χ<sup>2</sup> test, Fisher’s exact test, Mann–Whitney test, and Kruskall–Wallis test were used for comparison of categorical and continuous variables as appropriate. In Cox regression analysis, mortality predictors were tested in an univariable model and only significant predictors were entered in a multivariable backwards stepwise model. The statistical significance level was <italic>P</italic>&lt; 0.05 (two-sided test). Data were analyzed using the PASW Statistics software package, version 18 (SPSS, Inc., Chicago, Illinois, USA).</p>
</sec>
</sec>
<sec id="section11-2048872612455143" sec-type="results">
<title>Results</title>
<p>We identified 472 patients with entries in both pre- and in-hospital databases, based on 238 cases in zone 1, 115 patients in zone 2 and 119 patients in zone 3. The groups were well-balanced in terms of baseline and procedural variables (<xref ref-type="table" rid="table1-2048872612455143">Table 1</xref>). Pre-procedural thrombolysis in myocardial infarction (TIMI) 0 flow was significantly more frequent in zone 1 compared to zones 2 and 3 (<italic>p</italic>= 0.021).</p>
<table-wrap id="table1-2048872612455143" position="float">
<label>Table 1.</label>
<caption><p>Baseline characteristics.</p></caption>
<graphic alternate-form-of="table1-2048872612455143" xlink:href="10.1177_2048872612455143-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Zone 1 (0–25 km ) (<italic>n</italic>=238)</th>
<th align="left">Zone 2 (65–100 km) (<italic>n</italic>=115)</th>
<th align="left">Zone 3 (100–185 km) (<italic>n</italic>=119)</th>
<th align="left"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age</td>
<td>63 (54–71)</td>
<td>62 (54–72)</td>
<td>66.5 (56–73)</td>
<td>0.242</td>
</tr>
<tr>
<td>Male</td>
<td>174 (73.1)</td>
<td>89 (77.4)</td>
<td>90 (75.6)</td>
<td>0.525</td>
</tr>
<tr>
<td>Hypertension</td>
<td>73 (38.4)</td>
<td>40 (39.2)</td>
<td>34 (32.1)</td>
<td>0.323</td>
</tr>
<tr>
<td>Diabetes</td>
<td>23 (11.2)</td>
<td>9 (8.3)</td>
<td>11 (9.8)</td>
<td>0.629</td>
</tr>
<tr>
<td>Dyslipidemia</td>
<td>35 (25.5)</td>
<td>26 (32.5)</td>
<td>17 (21)</td>
<td>0.598</td>
</tr>
<tr>
<td>Family history of IHD</td>
<td>73 (41.5)</td>
<td>28 (30.8)</td>
<td>28 (30.4)</td>
<td>0.050</td>
</tr>
<tr>
<td>Current smoking</td>
<td>135 (67.5)</td>
<td>59 (56.7)</td>
<td>56 (54.9)</td>
<td>0.022</td>
</tr>
<tr>
<td>BMI</td>
<td>25.6 (23.2–29.3)</td>
<td>25.8 (23.3–28.4)</td>
<td>27 (24.6–30.3)</td>
<td>0.202</td>
</tr>
<tr>
<td>Prior MI</td>
<td>8 (9.1)</td>
<td>8 (14.5)</td>
<td>4 (9.1)</td>
<td>0.836</td>
</tr>
<tr>
<td>Prior PCI</td>
<td>17 (7.1)</td>
<td>8 (7)</td>
<td>9 (7.6)</td>
<td>0.903</td>
</tr>
<tr>
<td>Culprit</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>LAD</td>
<td>98 (42.1)</td>
<td>51 (44.3)</td>
<td>55 (47)</td>
<td>0.375</td>
</tr>
<tr>
<td>LCX</td>
<td>33 (14.2)</td>
<td>18 (15.7)</td>
<td>14 (12)</td>
<td>0.654</td>
</tr>
<tr>
<td>RCA</td>
<td>98 (42.1)</td>
<td>46 (40)</td>
<td>48 (41)</td>
<td>0.812</td>
</tr>
<tr>
<td>LM</td>
<td>5 (2.1)</td>
<td>0 (0)</td>
<td>1 (0.9)</td>
<td>0.216</td>
</tr>
<tr>
<td>Anterior infarction</td>
<td>103 (46.4)</td>
<td>54 (47.4)</td>
<td>55 (47)</td>
<td>0.898</td>
</tr>
<tr>
<td>Multiple vessel disease</td>
<td>60 (25.2)</td>
<td>31 (27)</td>
<td>27(22.7)</td>
<td>0.678</td>
</tr>
<tr>
<td>Acetylsalicylic acid</td>
<td>205 (91.1)</td>
<td>110 (96.5)</td>
<td>113 (95.8)</td>
<td>0.059</td>
</tr>
<tr>
<td>Clopidogrel</td>
<td>203 (90.2)</td>
<td>104 (91.2)</td>
<td>115 (97.5)</td>
<td>0.023</td>
</tr>
<tr>
<td>Heparin</td>
<td>157 (69.8)</td>
<td>111 (97.4)</td>
<td>113 (95.8)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>GP IIb/IIIa inhib.</td>
<td>127 (62.3)</td>
<td>91 (83.5)</td>
<td>88 (82.2)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>Bivalirudin</td>
<td>67 (32.8)</td>
<td>1 (0.9)</td>
<td>0 (0)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>Pre-procedural TIMI flow</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>0</td>
<td>141 (59.7)</td>
<td>60 (53.1)</td>
<td>54 (47)</td>
<td>0.021</td>
</tr>
<tr>
<td>1</td>
<td>12 (5.1)</td>
<td>9 (8)</td>
<td>12 (10.4)</td>
<td>0.061</td>
</tr>
<tr>
<td>2</td>
<td>34 (14.4)</td>
<td>22 (19.5)</td>
<td>22 (19.1)</td>
<td>0.213</td>
</tr>
<tr>
<td>3</td>
<td>49 (20.8)</td>
<td>22 (19.5)</td>
<td>27 (23.5)</td>
<td>0.626</td>
</tr>
<tr>
<td>Post-procedural TIMI flow 3</td>
<td>213 (90.6)</td>
<td>104 (92)</td>
<td>104 (90.4)</td>
<td>0.793</td>
</tr>
<tr>
<td>Peri-procedural cardiogenic shock</td>
<td>14 (5.9)</td>
<td>2 (1.7)</td>
<td>3 (2.5)</td>
<td>0.081</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-2048872612455143">
<p>BMI: body mass index; CABG: coronary artery bypass graft; IHD: ischemic heart disease; LAD: left anterior descending artery; LCX: left circumflex artery; LM: left main coronary artery; MI: myocardial infarction; PCI: percutaneous coronary intervention; RCA: right coronary artery; TIMI: thrombolysis in myocardial infarction; GP IIb/IIIa inhib.: glycoprotein IIb/IIIa inhibitor.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section12-2048872612455143">
<title>Temporal trends in diagnosis and referral</title>
<p>Time analysis is displayed in <xref ref-type="table" rid="table2-2048872612455143">Table 2</xref>. System and PCI-related delay in zones 2 and 3 were significantly longer compared to zone 1 (&lt;0.001) (<xref ref-type="table" rid="table2-2048872612455143">Table 2</xref> and <xref ref-type="fig" rid="fig2-2048872612455143">Figure 2</xref>). Patients in zones 2 and 3 were sub-stratified according to direct or non-direct referral by pre-hospital triage. In zones 2 and 3, 80 (34%) patients were transferred to the PPCI center via a local hospital. Seventeen of these (7%) had presented themselves at the local hospital and were excluded from the time analysis presented in <xref ref-type="fig" rid="fig2-2048872612455143">Figures 2</xref> and <xref ref-type="fig" rid="fig3-2048872612455143">3</xref>, as self-presenters have not been in contact with the EMS at injury site and therefore cannot be subject to pre-hospital triage. This yielded 73% of patients with direct referral for PPCI. Patients with non-direct referral spent 70 (46–150) min at the local hospital. There was significantly prolonged PCI-related delay (219 min (171–250) vs 121 (106–149) (&lt;0.001)) in the non-direct referral group vs the direct referral group (<xref ref-type="fig" rid="fig2-2048872612455143">Figure 2</xref>). We explored the reasons for indirect referral in <xref ref-type="fig" rid="fig3-2048872612455143">Figure 3</xref>. PCI-related delay was 109 min (92–122) in zone 2 and 139 min (121–160) in zone 3 for directly referred patients.</p>
<table-wrap id="table2-2048872612455143" position="float">
<label>Table 2.</label>
<caption><p>Median time intervals according to geographic zone 1–3.</p></caption>
<graphic alternate-form-of="table2-2048872612455143" xlink:href="10.1177_2048872612455143-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left" colspan="3">Median time intervals in minutes<hr/></th>
<th align="left"><italic>P</italic> value</th>
</tr>
<tr>
<th/>
<th align="left">Zone 1 (0–25 km) (<italic>n</italic>=238)</th>
<th align="left">Zone 2 (65–100 km) (<italic>n</italic>=115)</th>
<th align="left">Zone 3 (100–185 km) (<italic>n</italic>=119)</th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td>Patient delay</td>
<td>41 (15–85)</td>
<td>75 (29–170)</td>
<td>52 (26–99)</td>
<td>0.009</td>
</tr>
<tr>
<td>Call to scene</td>
<td>6 (4–7)</td>
<td>17 (10–22)</td>
<td>14 (10–19)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>Time at scene</td>
<td>20 (15–25)</td>
<td>16 (8–22)</td>
<td>18 (12–23)</td>
<td>0.002</td>
</tr>
<tr>
<td>Scene to PCI center</td>
<td>9 (7–12)</td>
<td>60 (50–70)</td>
<td>91 (75–125)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>Door to balloon</td>
<td>45 (33–70)</td>
<td>30 (20–39)</td>
<td>30 (23–45)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>Pre-hospital delay</td>
<td>35 (29–43)</td>
<td>98 (82–129)</td>
<td>135 (110–173)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>PCI-related delay</td>
<td>79 (65–100)</td>
<td>119 (102–168)</td>
<td>160 (128–210)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>System delay</td>
<td>86 (72–113)</td>
<td>133 (116–180)</td>
<td>173 (145–215)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>Treatment delay</td>
<td>135 (100–200)</td>
<td>235 (158–350)</td>
<td>235 (187–330)</td>
<td>&lt;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-2048872612455143">
<p>PCI: percutaneous coronary intervention.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-2048872612455143" position="float">
<label>Figure 2.</label>
<caption><p>System delay (emergency medical services (EMS) call to balloon) and first medical contact (FMC) to first balloon inflation in minutes (median; interquartile range (IQR)) according to zones or direct/non-direct referral.</p>
<p>IHF: in-hospital fibrinolysis; PCI: percutaneous coronary intervention; PHF: pre-hospital fibrinolysis.</p></caption>
<graphic xlink:href="10.1177_2048872612455143-fig2.tif"/></fig>
<fig id="fig3-2048872612455143" position="float">
<label>Figure 3.</label>
<caption><p>Reasons for indirect referral in zones 2 and 3. Percentages are given for the overall population in zones 2 and 3 (<italic>n</italic>=234). Atrioventricular block (AV) &gt;2<sup>nd</sup> degree.</p>
<p>VF: ventricular fibrillation; VT: ventricular tachycardia.</p></caption>
<graphic xlink:href="10.1177_2048872612455143-fig3.tif"/></fig>
</sec>
<sec id="section13-2048872612455143">
<title>Transfer complications and mortality rates</title>
<p>The incidence ventricular fibrillation (VF)/ventricular tachycardia (VT)/asystole, AV-block &gt;2<sup>nd</sup> degree, Killip Class 2–4, hypotension (systolic blood pressure (SBT) &lt;100) and tachycardia (heart rate &gt;100) did not differ significantly between zones (<xref ref-type="table" rid="table3-2048872612455143">Table 3</xref>). Mortality rates were analyzed for the first 24 hours, 7 days, 30 days and at final follow up (median 4.3 years). There were no significant differences in mortality rates at 7 days, 30 days or final follow up. In zone 1, there was a significantly higher mortality rate (<italic>p</italic>=0.036) during the first 24 hours after admittance to PPCI (<xref ref-type="table" rid="table3-2048872612455143">Table 3</xref>). Tachycardia, hypotension, door-to-balloon and system delay were independent predictors of mortality at final follow up (<xref ref-type="table" rid="table4-2048872612455143">Table 4</xref>).</p>
<table-wrap id="table3-2048872612455143" position="float">
<label>Table 3.</label>
<caption><p>Complications during transfer and mortality rates.</p></caption>
<graphic alternate-form-of="table3-2048872612455143" xlink:href="10.1177_2048872612455143-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Zone 1</th>
<th align="left">Zone 2</th>
<th align="left">Zone 3</th>
<th align="left"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td>VF/VT/asystole</td>
<td>18 (7.6)</td>
<td>12 (10.4)</td>
<td>14 (11.8)</td>
<td>0.178</td>
</tr>
<tr>
<td>SBT &lt;100</td>
<td>49 (20.6)</td>
<td>11 (9.6)</td>
<td>18 (15.1)</td>
<td>0.092</td>
</tr>
<tr>
<td>Heart rate&gt;100</td>
<td>33 (13.9)</td>
<td>21 (18.9)</td>
<td>14 (11.4)</td>
<td>0.736</td>
</tr>
<tr>
<td>AV block &gt;2<sup>nd</sup> degree</td>
<td>4 (1.7)</td>
<td>4 (3.5)</td>
<td>2 (1.7)</td>
<td>0.842</td>
</tr>
<tr>
<td>Killip class 2–4</td>
<td>26 (11.8)</td>
<td>13 (12.5)</td>
<td>8 (7.8)</td>
<td>0.731</td>
</tr>
<tr>
<td>Mortality within 24 hours</td>
<td>10 (4.2)</td>
<td>1 (0.9)</td>
<td>1 (0.8)</td>
<td>0.036</td>
</tr>
<tr>
<td>Mortality within 7 days</td>
<td>16 (6.8)</td>
<td>4 (3.5)</td>
<td>5 (4.2)</td>
<td>0.239</td>
</tr>
<tr>
<td>Mortality within 30 days</td>
<td>19 (8.1)</td>
<td>7 (6.1)</td>
<td>8 (6.8)</td>
<td>0.501</td>
</tr>
<tr>
<td>Mortality at final follow up</td>
<td>56 (23.8)</td>
<td>23 (20)</td>
<td>20 (16.9)</td>
<td>0.126</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-2048872612455143">
<p>AV: atrioventricular; SBT: systolic blood pressure; VF: ventricular fibrillation; VT: ventricular tachycardia.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table4-2048872612455143" position="float">
<label>Table 4.</label>
<caption><p>Univariable and multivariable predictors for long term all cause mortality.Univariable and multivariable predictors for long term all cause mortality in the entire population. Hypertension, Hypercholesterolemia, diabetes, smoking status, former MI, AV block &gt;2<sup>nd</sup> deg., patient delay, pre-hospital delay, door to balloon, treatment delay were also tested for univariable prediction but were non significant. In addition to significant univariable predictors, model 1 adjusts for door-to-balloon and model 2 for system delay.</p></caption>
<graphic alternate-form-of="table4-2048872612455143" xlink:href="10.1177_2048872612455143-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left" colspan="2">Univariable predictors<hr/></th>
<th align="left" colspan="2">Multivariable predictors Model 1<hr/></th>
<th align="left" colspan="2">Multivariable predictors Model 2<hr/></th>
</tr>
<tr>
<th/>
<th align="left">HR (95% CI)</th>
<th align="left"><italic>p</italic></th>
<th align="left">HR (95% CI)</th>
<th align="left"><italic>p</italic></th>
<th align="left">HR (95% CI)</th>
<th align="left"><italic>p</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (per year)</td>
<td>1.072 (1.053–1.091)</td>
<td>&lt;0.001</td>
<td>1.066 (1.045–1.087)</td>
<td>&lt;0.001</td>
<td>1.066 (1.047–1.085)</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>SBT &lt;100</td>
<td>2.171 (1.401–3.364)</td>
<td>&lt;0.001</td>
<td>1.793 (1.018–3.158)</td>
<td>0.043</td>
<td>2.241 (1.376–3.650)</td>
<td>0.001</td>
</tr>
<tr>
<td>Heart rate&gt;100</td>
<td>2.229 (1.407–3.532)</td>
<td>&lt;0.001</td>
<td>2.308 (1.314–4.054)</td>
<td>0.004</td>
<td>2.091 (1.268–3.448)</td>
<td>0.004</td>
</tr>
<tr>
<td>Killip class 2–4</td>
<td>3.229 (1.872–5.572)</td>
<td>&lt;0.001</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Patient delay</td>
<td>1.000 (0.998–1.002)</td>
<td>0.783</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Pre-hospital delay</td>
<td>1.001 (0.997–1.004)</td>
<td>0.402</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Door-to-balloon</td>
<td>1.005 (1.002–1.009)</td>
<td>0.003</td>
<td>1.004 (1.001–1.008)</td>
<td>0.017</td>
<td/>
<td/>
</tr>
<tr>
<td>System delay (per min)</td>
<td>1.004 (1.002–1.006)</td>
<td>&lt;0.001</td>
<td/>
<td/>
<td>1.003 (1.001–1.005)</td>
<td>0.005</td>
</tr>
<tr>
<td>Treatment delay</td>
<td>1.000 (0.998–1.002)</td>
<td>0.898</td>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-2048872612455143">
<p>AV: atrioventricular; CI: confidence interval; SBT: MI: myocardial infarction; systolic blood pressure; HR: heart rate.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section14-2048872612455143" sec-type="discussion">
<title>Discussion</title>
<p>In this ‘real world’ registry study from a small homogenous area with implemented tele-transmission of digital ECG, field triage and direct transfer to a PCI-capable center around the clock, the main finding is that reperfusion is still delayed beyond current ESC recommendations (<xref ref-type="table" rid="table2-2048872612455143">Table 2</xref> and <xref ref-type="fig" rid="fig2-2048872612455143">Figure 2</xref>).<sup><xref ref-type="bibr" rid="bibr5-2048872612455143">5</xref></sup> PCI-related delay in the overall population was borderline with regard to ESC guidelines (&lt;120 min) for patients in zone 2 (119 min), but exceeded recommendations in zone 3 (160 min) (<xref ref-type="table" rid="table2-2048872612455143">Table 2</xref>). Among patients transported by EMS from injury scene, 73% were field-triaged directly to PPCI. A recent study from Western Denmark found a practically identical proportion of 72%.<sup><xref ref-type="bibr" rid="bibr18-2048872612455143">18</xref></sup> The effectiveness of pre-hospital triage is highlighted by 219 min system delay among non-directly transferred patients (<xref ref-type="fig" rid="fig2-2048872612455143">Figure 2</xref>). Seventy minutes were spent at the local hospital. In patients transferred by direct referral only, PCI-related delay was 109 min in zone 2 and 139 min in zone 3. Also in directly referred younger patients (&lt;75 years) with anterior STEMI, PCI-related delay exceeded ESC guidelines (90 min) in zone 2 (113 min (118–210)) and zone 3 (144 min (124–159)).</p>
<sec id="section15-2048872612455143">
<title>PCI-related delay</title>
<p>Recently the ESC paradigm of an acceptable two hour limit from FMC has been disputed.<sup><xref ref-type="bibr" rid="bibr17-2048872612455143">17</xref>,<xref ref-type="bibr" rid="bibr19-2048872612455143">19</xref></sup> Given a maximum acceptable PCI-related delay of 120 min (instead of administering fibrinolysis), the maximum acceptable time from FMC to PPCI would be 150 min: 120+30 min (30 min estimated door-to-needle time in case of in-hospital fibrinolysis or typical time consumption from EMS arrival to pre-hospital fibrinolysis initiation).<sup><xref ref-type="bibr" rid="bibr20-2048872612455143">20</xref></sup> When in-hospital fibrinolysis is considered the alternative, acceptable PPCI-related delay increases for every minute of transport to the local hospital. Scene time (18 min (10–24)) added to time from scene departure to local hospital (21 min (15–34)) yields an acceptable PCI-related delay of 150+18+21=189 min. Provided they were referred directly, roughly all patients transferred up to 185 km (zones 1–3) obtained timely reperfusion within this in-hospital fibrinolysis time limit. Contrary hereto, only 62.3% of directly referred patients from zone 3 (&gt;100 km) (<xref ref-type="fig" rid="fig3-2048872612455143">Figure 3</xref>) were treated with PPCI within 150 min (pre-hospital fibrinolysis limit) and only 16.3% and 32.7% of patients referred non-directly in zones 2 and 3 were treated with PPCI within 150 min and 189 min respectively. This possibly implies a role for pre-hospital fibrinolysis in patients transferred &gt;100 km and for patients &lt;75 years with anterior infarctions, as well as a role for in-hospital fibrinolysis in patients indirectly transferred. The reasons for indirect referral are shown in <xref ref-type="fig" rid="fig4-2048872612455143">Figure 4</xref>, of notice only 10% of the overall 234 patients in zones 2 and 3 were non-directly transferred in spite of ST-segment elevation in the pre-hospital ECG, an obvious requirement for initiating pre-hospital fibrinolysis.</p>
<fig id="fig4-2048872612455143" position="float">
<label>Figure 4.</label>
<caption><p>Number of patients (%) that meet European Society of Cardiology (ESC) guidelines criteria for reperfusion with primary percutaneous coronary intervention (PPCI) within 120 minutes (blue); Number of patients (%) that stay below the time limit for PCI-related delay, above which pre-hospital fibrinolysis (PHF) has a theoretical advantage over PPCI (red); Number of patients (%) that stay below the time limit for PCI-related delay, above which in-hospital fibrinolysis (IHF) has a theoretical advantage over primary PCI (green). (A) overall population; (B) only directly referred patients.</p></caption>
<graphic xlink:href="10.1177_2048872612455143-fig4.tif"/></fig>
</sec>
<sec id="section16-2048872612455143">
<title>Alternative reperfusion regiments</title>
<p>Meta-analyses of randomized trials,<sup><xref ref-type="bibr" rid="bibr21-2048872612455143">21</xref>,<xref ref-type="bibr" rid="bibr22-2048872612455143">22</xref></sup> registry studies<sup><xref ref-type="bibr" rid="bibr23-2048872612455143">23</xref></sup> and sub-analyses<sup><xref ref-type="bibr" rid="bibr24-2048872612455143">24</xref></sup> have all found that PPCI is superior to fibrinolysis at PCI-related delays up to 120 min, but the PPCI mortality advantage disappears as PCI-related delay increases.<sup><xref ref-type="bibr" rid="bibr25-2048872612455143">25</xref></sup> Pre-hospital fibrinolysis with trained EMS paramedics reduces delay and mortality in comparison to in-hospital fibrinolysis,<sup><xref ref-type="bibr" rid="bibr20-2048872612455143">20</xref>,<xref ref-type="bibr" rid="bibr26-2048872612455143">26</xref></sup> and compares well with PPCI when given within two hours, regarding one-year mortality rates.<sup><xref ref-type="bibr" rid="bibr23-2048872612455143">23</xref></sup> In a pooled analysis of the only two randomized studies comparing pre-hospital fibrinolysis with PPCI, one-year mortality in patients treated with pre-hospital fibrinolysis was significantly reduced when treated within two hours of symptom onset.<sup><xref ref-type="bibr" rid="bibr27-2048872612455143">27</xref>,<xref ref-type="bibr" rid="bibr28-2048872612455143">28</xref></sup></p>
<p>The ‘pharmacoinvasive’ strategy combining early fibrinolysis (&lt;3 hours after symptom onset) with early PCI (within 24 hours of fibrinolysis) yields survival rates comparable to PPCI<sup><xref ref-type="bibr" rid="bibr29-2048872612455143">29</xref></sup> and is superior to a rescue PCI strategy,<sup><xref ref-type="bibr" rid="bibr30-2048872612455143">30</xref></sup> yet a facilitated PPCI strategy with very early PPCI (1–3 hours) after fibrinolysis was associated with more major adverse events.<sup><xref ref-type="bibr" rid="bibr31-2048872612455143">31</xref></sup> Patients with long and non-direct transferrals (&gt;97 km) (comparable to zone 3) treated with the pharmaco-invasive approach obtain a similar outcome to patients admitted directly to PPCI from shorter distances,<sup><xref ref-type="bibr" rid="bibr32-2048872612455143">32</xref></sup> and a pharmaco-invasive approach might even be preferred in high-risk STEMI patients who present early to a non-PCI center.<sup><xref ref-type="bibr" rid="bibr33-2048872612455143">33</xref></sup> Alternatives strategies could be pre-hospital glycoprotein IIb/IIIa inhibitors,<sup><xref ref-type="bibr" rid="bibr34-2048872612455143">34</xref>,<xref ref-type="bibr" rid="bibr35-2048872612455143">35</xref></sup> or bivalirudin.<sup><xref ref-type="bibr" rid="bibr36-2048872612455143">36</xref></sup> and results from ongoing randomized trials are awaited.</p>
</sec>
<sec id="section17-2048872612455143">
<title>Limitations</title>
<p>Patients are not consecutive as they were selected by having data entries in both pre- and in-hospital databases, with the inherent risk of selection bias. However baseline variables were well-balanced. We confirmed that system delay independently predicts long mortality,<sup><xref ref-type="bibr" rid="bibr4-2048872612455143">4</xref></sup> and ground transfer of STEMI patients is safe,<sup><xref ref-type="bibr" rid="bibr8-2048872612455143">8</xref></sup> (<xref ref-type="table" rid="table3-2048872612455143">Table 3</xref>) yet long term mortality between zones did not differ. This is probably due to a higher mortality in the first 24 hours (<xref ref-type="table" rid="table3-2048872612455143">Table 3</xref>) in zone 1. We interpret these findings as inherent to our inclusion criteria of having PPCI performed, as only patients who survived until PPCI were able to enter the database with a PPCI procedure code. Longer transfer distances likely entail a smaller inclination to transfer morbid patients, yielding a natural selection of survivors from zones 2 and 3 for PPCI. This is supported by the higher occurrence of peri-procedural cardiogenic shock in zone 1 (<xref ref-type="table" rid="table1-2048872612455143">Table 1</xref>). Disregarding mortality during the first 24 hours yields mortality rates that are more alike for all three zones. Lower blood pressure values during transfer in zone 1 could also be explained by more frequent use of intravenous β-blockers in zone 1 compared to zones 2 and 3 (9.8% vs 4.8%, <italic>P</italic>=0.042). The discrepancy in administration of bivalirudin, heparin and GP IIb/IIIa inhibitors (<xref ref-type="table" rid="table1-2048872612455143">Table 1</xref>) is due to a feasibility study regarding pre-hospital administration of bivalirudin vs. heparin performed in zone 1 during this study’s inclusion period.<sup><xref ref-type="bibr" rid="bibr36-2048872612455143">36</xref></sup></p>
<p>Only 7% of patients in this selected population were self-presenters. It is important to emphasize that this study concentrates on EMS-activated patients and likely underestimates the true dimension of self transport to a PCI or non-PCI Center.<sup><xref ref-type="bibr" rid="bibr18-2048872612455143">18</xref></sup> Finally overall sample size may be too small to demonstrate consistent mortality differences between zones and complete mortality associations with baseline or procedural variables.</p>
</sec>
</sec>
<sec id="section18-2048872612455143" sec-type="conclusions">
<title>Conclusion</title>
<p>Pre-hospital triage is feasible in 73% of STEMI patients. In spite of implemented telemedicine, reperfusion with PPCI was delayed beyond ESC guideline recommendations for patients living &gt;100 km away and for patients being non-directly referred. System delay predicts all-cause mortality in STEMI patients and therefore pre-hospital triage should ensure the necessary expertise with EMS to allow direct transfer in as many STEMI patients as possible, as admission via a local hospital delays optimal care. Geographical zone stratification, enables identification of patients with long PCI-related delays. Pharmaco-invasive regiments, research in early ischemia detection, further EMS personnel education, and airborne transfer are possible options.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This work was supported by grants from the Rigshospitalets Research Foundation and the Vera &amp; Flemming Westerberg Foundation.</p></fn>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>None declared</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-2048872612455143">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eitel</surname><given-names>I</given-names></name>
<name><surname>Desch</surname><given-names>S</given-names></name>
<name><surname>Fuernau</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction</article-title>. <source>J Am Coll Cardiol</source> <year>2010</year>; <volume>55</volume>: <fpage>2470</fpage>–<lpage>2479</lpage>.</citation>
</ref>
<ref id="bibr2-2048872612455143">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Francone</surname><given-names>M</given-names></name>
<name><surname>Bucciarelli-Ducci</surname><given-names>C</given-names></name>
<name><surname>Carbone</surname><given-names>I</given-names></name><etal/>
</person-group>. <article-title>Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance</article-title>. <source>J Am Coll Cardiol</source> <year>2009</year>; <volume>54</volume>: <fpage>2145</fpage>–<lpage>2153</lpage>.</citation>
</ref>
<ref id="bibr3-2048872612455143">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Terkelsen</surname><given-names>CJ</given-names></name>
<name><surname>Jensen</surname><given-names>LO</given-names></name>
<name><surname>Tilsted</surname><given-names>HH</given-names></name><etal/>
</person-group>. <article-title>Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data</article-title>. <source>Ann Intern Med</source> <year>2011</year>; <volume>155</volume>: <fpage>361</fpage>–<lpage>367</lpage>.</citation>
</ref>
<ref id="bibr4-2048872612455143">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Terkelsen</surname><given-names>CJ</given-names></name>
<name><surname>Sørensen</surname><given-names>JT</given-names></name>
<name><surname>Maeng</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention</article-title>. <source>JAMA</source> <year>2010</year>; <volume>304</volume>: <fpage>763</fpage>–<lpage>771</lpage>.</citation>
</ref>
<ref id="bibr5-2048872612455143">
<label>5.</label>
<citation citation-type="journal">
<collab>Guidelines on myocardial revascularization</collab>.<article-title>The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)</article-title>. <source>Eur Heart J</source> <year>2010</year>; <volume>31</volume>: <fpage>2501</fpage>–<lpage>2555</lpage>.</citation>
</ref>
<ref id="bibr6-2048872612455143">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sejersten</surname><given-names>M</given-names></name>
<name><surname>Sillesen</surname><given-names>M</given-names></name>
<name><surname>Hansen</surname><given-names>PR</given-names></name><etal/>
</person-group>. <article-title>Effect on treatment delay of prehospital teletransmission of 12-lead electrocardiogram to a cardiologist for immediate triage and direct referral of patients with ST-segment elevation acute myocardial infarction to primary percutaneous coronary intervention</article-title>. <source>Am J Cardiol</source> <year>2008</year>; <volume>101</volume>: <fpage>941</fpage>–<lpage>946</lpage>.</citation>
</ref>
<ref id="bibr7-2048872612455143">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gheeraert</surname><given-names>PJ</given-names></name>
<name><surname>De Buyzere</surname><given-names>ML</given-names></name>
<name><surname>Taeymans</surname><given-names>YM</given-names></name><etal/>
</person-group>. <article-title>Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis</article-title>. <source>Eur Heart J</source> <year>2006</year>; <volume>27</volume>: <fpage>2499</fpage>–<lpage>2510</lpage>.</citation>
</ref>
<ref id="bibr8-2048872612455143">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andersen</surname><given-names>HR</given-names></name>
<name><surname>Nielsen</surname><given-names>TT</given-names></name>
<name><surname>Rasmussen</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction</article-title>. <source>N Engl J Med</source> <year>2003</year>; <volume>349</volume>: <fpage>733</fpage>–<lpage>742</lpage>.</citation>
</ref>
<ref id="bibr9-2048872612455143">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huber</surname><given-names>K</given-names></name>
<name><surname>Goldstein</surname><given-names>P</given-names></name>
<name><surname>Danchin</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Network models for large cities: the European experience</article-title>. <source>Heart</source> <year>2010</year>; <volume>96</volume>: <fpage>164</fpage>–<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr10-2048872612455143">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kalla</surname><given-names>K</given-names></name>
<name><surname>Christ</surname><given-names>G</given-names></name>
<name><surname>Karnik</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Implementation of guidelines improves the standard of care</article-title>. <source>Circulation</source> <year>2006</year>; <volume>113</volume>: <fpage>2398</fpage>–<lpage>2405</lpage>.</citation>
</ref>
<ref id="bibr11-2048872612455143">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ting</surname><given-names>HH</given-names></name>
<name><surname>Rihal</surname><given-names>CS</given-names></name>
<name><surname>Gersh</surname><given-names>BJ</given-names></name><etal/>
</person-group>. <article-title>Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction</article-title>. <source>Circulation</source> <year>2007</year>; <volume>116</volume>: <fpage>729</fpage>–<lpage>736</lpage>.</citation>
</ref>
<ref id="bibr12-2048872612455143">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jollis</surname><given-names>JG</given-names></name>
<name><surname>Roettig</surname><given-names>ML</given-names></name>
<name><surname>Aluko</surname><given-names>AO</given-names></name><etal/>
</person-group>. <article-title>Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction</article-title>. <source>JAMA</source> <year>2007</year>; <volume>298</volume>: <fpage>2371</fpage>–<lpage>2380</lpage>.</citation>
</ref>
<ref id="bibr13-2048872612455143">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Le May</surname><given-names>MR</given-names></name>
<name><surname>So</surname><given-names>DY</given-names></name>
<name><surname>Dionne</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>A citywide protocol for primary PCI in ST-segment elevation myocardial infarction</article-title>. <source>N Engl J Med</source> <year>2008</year>; <volume>358</volume>: <fpage>231</fpage>–<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr14-2048872612455143">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saif</surname><given-names>SR</given-names></name>
<name><surname>Jeptha</surname><given-names>PC</given-names></name>
<name><surname>Jersey</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study</article-title>. <source>BMJ</source> <year>2009</year>; <volume>338</volume>: <fpage>b1807</fpage>.</citation>
</ref>
<ref id="bibr15-2048872612455143">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Antman</surname><given-names>EM</given-names></name>
<name><surname>Hand</surname><given-names>M</given-names></name>
<name><surname>Armstrong</surname><given-names>PW</given-names></name><etal/>
</person-group>. <article-title>2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction</article-title>. <source>Circulation</source> <year>2008</year>; <volume>117</volume>: <fpage>296</fpage>–<lpage>329</lpage>.</citation>
</ref>
<ref id="bibr16-2048872612455143">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van</surname><given-names>de</given-names></name>
<name><surname>Werf</surname><given-names>F</given-names></name>
<name><surname>Bax</surname><given-names>J</given-names></name>
<name><surname>Betriu</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation</article-title>. <source>Eur Heart J</source> <year>2008</year>; <volume>29</volume>: <fpage>2909</fpage>–<lpage>2945</lpage>.</citation>
</ref>
<ref id="bibr17-2048872612455143">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Terkelsen</surname><given-names>CJ</given-names></name>
<name><surname>Christiansen</surname><given-names>EH</given-names></name>
<name><surname>Sørensen</surname><given-names>JT</given-names></name><etal/>
</person-group>. <article-title>Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time</article-title>. <source>Heart</source> <year>2009</year>; <volume>95</volume>: <fpage>362</fpage>–<lpage>369</lpage>.</citation>
</ref>
<ref id="bibr18-2048872612455143">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Terkelsen</surname><given-names>CJ</given-names></name>
<name><surname>Jensen</surname><given-names>LO</given-names></name>
<name><surname>Tilsted</surname><given-names>HH</given-names></name><etal/>
</person-group>. <article-title>Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarction</article-title>. <source>Circ Cardiovasc Interv</source> <year>2011</year>; <volume>4</volume>: <fpage>361</fpage>–<lpage>367</lpage>.</citation>
</ref>
<ref id="bibr19-2048872612455143">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Terkelsen</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>CardioPulse: should the rebellious Danes stay with the balloons or should they adhere to the 2008 ESC ST-elevation myocardial infarction guidelines and re-introduce the lytics?</article-title> <source>Eur Heart J</source> <year>2010</year>; <volume>31</volume>: <fpage>1541</fpage>–<lpage>1547</lpage>.</citation>
</ref>
<ref id="bibr20-2048872612455143">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bjørklund</surname><given-names>E</given-names></name>
<name><surname>Stenestrand</surname><given-names>U</given-names></name>
<name><surname>Lindbäck</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction</article-title>. <source>Eur Heart J</source> <year>2006</year>; <volume>27</volume>: <fpage>1146</fpage>–<lpage>1152</lpage>.</citation>
</ref>
<ref id="bibr21-2048872612455143">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Keeley</surname><given-names>EC</given-names></name>
<name><surname>Boura</surname><given-names>JA</given-names></name>
<name><surname>Grines</surname><given-names>CL</given-names></name>
</person-group>. <article-title>Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials</article-title>. <source>Lancet</source> <year>2003</year>; <volume>361</volume>: <fpage>13</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr22-2048872612455143">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boersma</surname><given-names>E</given-names></name>
</person-group> <collab>and The Primary Coronary Angioplasty vs Thrombolysis (PCAT) Group</collab>. <article-title>Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients</article-title>. <source>Eur Heart J</source> <year>2006</year>; <volume>27</volume>: <fpage>779</fpage>–<lpage>788</lpage>.</citation>
</ref>
<ref id="bibr23-2048872612455143">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stenestrand</surname><given-names>U</given-names></name>
<name><surname>Lindbäck</surname><given-names>J</given-names></name>
<name><surname>Wallentin</surname><given-names>L</given-names></name><etal/>
</person-group>. <article-title>Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction</article-title>. <source>JAMA</source> <year>2006</year>; <volume>296</volume>: <fpage>1749</fpage>–<lpage>1756</lpage>.</citation>
</ref>
<ref id="bibr24-2048872612455143">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>PH</given-names></name>
<name><surname>Terkelsen</surname><given-names>CJ</given-names></name>
<name><surname>Nielsen</surname><given-names>TT</given-names></name><etal/>
</person-group>. <article-title>System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 (DANAMI-2) trial)</article-title>. <source>Am J Cardiol</source> <year>2011</year>; <volume>108</volume>: <fpage>776</fpage>–<lpage>781</lpage>.</citation>
</ref>
<ref id="bibr25-2048872612455143">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pinto</surname><given-names>DS</given-names></name>
<name><surname>Frederick</surname><given-names>PD</given-names></name>
<name><surname>Chakrabarti</surname><given-names>AK</given-names></name><etal/>
</person-group>. <article-title>Benefit of transferring ST-segment elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase</article-title>. <source>Circulation</source> <year>2011</year>; <volume>124</volume>: <fpage>2512</fpage>–<lpage>2521</lpage>.</citation>
</ref>
<ref id="bibr26-2048872612455143">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Welsh</surname><given-names>RC</given-names></name>
<name><surname>Travers</surname><given-names>A</given-names></name>
<name><surname>Senaratne</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center</article-title>. <source>Am Heart J</source> <year>2006</year>; <volume>152</volume>: <fpage>1007</fpage>–<lpage>1014</lpage>.</citation>
</ref>
<ref id="bibr27-2048872612455143">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bonnefoy</surname><given-names>E</given-names></name>
<name><surname>Steg</surname><given-names>PG</given-names></name>
<name><surname>Boutitie</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up</article-title>. <source>Eur Heart J</source> <year>2009</year>; <volume>30</volume>: <fpage>1598</fpage>–<lpage>1606</lpage>.</citation>
</ref>
<ref id="bibr28-2048872612455143">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Westerhout</surname><given-names>CM</given-names></name>
<name><surname>Bonnefoy</surname><given-names>E</given-names></name>
<name><surname>Welsh</surname><given-names>RC</given-names></name><etal/>
</person-group>. <article-title>The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST</article-title>. <source>Am Heart J</source> <year>2011</year>; <volume>161</volume>: <fpage>283</fpage>–<lpage>290</lpage>.</citation>
</ref>
<ref id="bibr29-2048872612455143">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Danchin</surname><given-names>N</given-names></name>
<name><surname>Coste</surname><given-names>P</given-names></name>
<name><surname>Ferrières</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction</article-title>. <source>Circulation</source> <year>2008</year>; <volume>118</volume>: <fpage>268</fpage>–<lpage>276</lpage>.</citation>
</ref>
<ref id="bibr30-2048872612455143">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borgia</surname><given-names>F</given-names></name>
<name><surname>Goodman</surname><given-names>SG</given-names></name>
<name><surname>Halvorsen</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis</article-title>. <source>Eur Heart J</source> <year>2010</year>; <volume>31</volume>: <fpage>2156</fpage>–<lpage>2169</lpage>.</citation>
</ref>
<ref id="bibr31-2048872612455143">
<label>31.</label>
<citation citation-type="journal">
<collab>Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators</collab>. <article-title>Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial</article-title>. <source>Lancet</source> <year>2006</year>; <volume>367</volume>: <fpage>569</fpage>–<lpage>578</lpage>.</citation>
</ref>
<ref id="bibr32-2048872612455143">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Henry</surname><given-names>TD</given-names></name>
<name><surname>Sharkey</surname><given-names>SW</given-names></name>
<name><surname>Burke</surname><given-names>MN</given-names></name><etal/>
</person-group>. <article-title>A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction</article-title>. <source>Circulation</source> <year>2007</year>; <volume>116</volume>: <fpage>721</fpage>–<lpage>728</lpage>.</citation>
</ref>
<ref id="bibr33-2048872612455143">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Herrmann</surname><given-names>HC</given-names></name>
<name><surname>Lu</surname><given-names>J</given-names></name>
<name><surname>Brodie</surname><given-names>BR</given-names></name><etal/>
</person-group>. <article-title>Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals</article-title>. <source>JACC Cardiovasc Interv</source> <year>2009</year>; <volume>2</volume>: <fpage>917</fpage>–<lpage>924</lpage>.</citation>
</ref>
<ref id="bibr34-2048872612455143">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hassan</surname><given-names>AKM</given-names></name>
<name><surname>Liem</surname><given-names>SS</given-names></name>
<name><surname>Van der Kley</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program</article-title>. <source>Catheter Cardiovasc Interv</source> <year>2009</year>; <volume>74</volume>: <fpage>335</fpage>–<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr35-2048872612455143">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heestermans</surname><given-names>T</given-names></name>
<name><surname>De Boer</surname><given-names>MJ</given-names></name>
<name><surname>Van Werkum</surname><given-names>JW</given-names></name><etal/>
</person-group>. <article-title>Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay</article-title>. <source>EuroIntervention</source> <year>2011</year>; <volume>7</volume>: <fpage>442</fpage>–<lpage>448</lpage>.</citation>
</ref>
<ref id="bibr36-2048872612455143">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sejersten</surname><given-names>M</given-names></name>
<name><surname>Nielsen</surname><given-names>SL</given-names></name>
<name><surname>Engstrøm</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction</article-title>. <source>Am J Cardiol</source> <year>2009</year>; <volume>103</volume>: <fpage>1635</fpage>–<lpage>1640</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>